Search Results - Gebrehiwet, Paulos

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Time from amyotrophic lateral sclerosis symptom onset to key disease milestones: analysis of data from a multinational cross-sectional survey

    Time from amyotrophic lateral sclerosis symptom onset to key disease milestones: analysis of data from a multinational cross-sectional survey by Gebrehiwet, Paulos, Brekke, Johan, Rudnicki, Stacy A, Mellor, Jennifer, Wright, Jack, Earl, Lucy, Ball, Nathan, Iqbal, Halima, Thomas, Owen, Castellano, Giorgio

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in pediatric and adult population: a systematic review and meta-analysis

    Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in pediatric and adult population: a systematic review and meta-analysis by Pande, Apurva, Lamba, Nayan, Mammi, Marco, Gebrehiwet, Paulos, Trenary, Alyssa, Doucette, Joanne, Papatheodorou, Stefania, Bunevicius, Adomas, Smith, Timothy R., Mekary, Rania A.

    Published in Neurosurgical review
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial

    MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial by Gebrehiwet, Paulos, Meng, Lisa, Rudnicki, Stacy A., Sarocco, Phil, Wei, Jenny, Wolff, Andrew A., Chiò, Adriano, Andrews, Jinsy A., Genge, Angela, Jackson, Carlayne E., Lechtzin, Noah, Miller, Timothy M., Shefner, Jeremy M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS

    Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS by Gebrehiwet, Paulos, Meng, Lisa, Rudnicki, Stacy A., Sarocco, Phil, Wei, Jenny, Wolff, Andrew A., Butzner, Michael, Chiò, Adriano, Andrews, Jinsy A., Genge, Angela, Hughes, Dyfrig A., Jackson, Carlayne E., Lechtzin, Noah, Miller, Timothy M., Shefner, Jeremy M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: